Synbio Technologies and GSL Biotech have finalized a non-exclusive agreement allowing customers of GSL Biotech’s “SnapGene” software to order constructs directly from Synbio Technologies after having designed them in SnapGene.
Fusion Antibodies Ltd (UK) and Synbio Technologies Co. Ltd (China/USA) are excited to announce a commercial partnership to support biologic drug development in China.
Synbio Technologies, a leading international synthetic biology service company, recently announced a new partnership with ALSTEM, LLC, a US biotech company, with the aim of developing various human CRISPR-sgRNA libraries.
Synbio Technologies will attend the 13th annual Essential Protein Engineering Summit (PEGS), May 1-5, 2017, at the Seaport World Trade Center in Boston, Massachusetts.
Twist Bioscience, a company accelerating science and innovation through rapid, high-quality DNA synthesis, today announced that it signed a non-exclusive agreement with Synbio Technologies. The companies will partner their respective capabilities to provide customers with access to long-length genes up to 70 kilobases.
Satisfied Users & 
Approved Press Releases
